3Marra MA, Jones ST, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science, 2003, 300 (5624) : 1399-1404,.
4Fouchier RA, Kuiken T, Schutten M, el al. Aetiology: Koch' s postulates fulfilled for SARS virus. Nature, 2003, 423 (6937): 240.
5WHO. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. 4 May, 2003.
6Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med, 2003, 348 (20): 1986-1994.
7Nicholls JM, Poon LL, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet, 2003, 361 (9371): 1773-1778.
8Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 2003, 361 (9366): 1319-1325.
9Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med, 2003, 348 (20) : 1995-2005.
10Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.JAMA, 2003, 289 (21) : 2801-2809.
6Chu CM, Poon I.LM , Cheng VCC, et al. Initial viral load and the outcomes of SARS[J]. Can Med Assoc J, 2004,171 (11).:1349- 1352.
7Leong HNam , Ang B, Earnest A, et al. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003 [J]. Trop Med Int Health, 2004, 9 (8):923-927.
8Poutanen SM,Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada[J]. N Engl J Med, 2003,348(20) : 1995-2005.
